Ambroxol Hydrochloride addresses respiratory conditions like productive cough and inflammatory disorders of the upper and lower respiratory tracts.
It effectively treats asthma with thick mucus, bronchiectasis, chronic pneumonia, and inflammatory diseases of the rhinopharyngeal tract.
As the active metabolite of bromhexine, Ambroxol improves sputum rheology by hydrating mechanisms, facilitating mucus liquefaction, and easing expectoration.
It exhibits anti-inflammatory properties, reducing bronchial hyperactivity and improving airway patency in patients with COPD.
Dosage varies by age and formulation, with options including pediatric drops, syrup, and sustained-release capsules for adults and older children.
